Sugi Predict

Sugi Predict / Compounds / SCHEMBL1781957

SCHEMBL1781957

SCHEMBL1781957

CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.46
▸ EPHX2 P34913 4/20 0.44
▸ TLR4 O00206 4/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CETP P11597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032741 0.95 TLR4 (0.47) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL1714235 0.92 LDHA (0.46) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL50419 0.92 LDHA (0.46) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL359493 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL337163 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL128339 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL313538 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL359292 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL15435964 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1
SCHEMBL39624 0.86 LDHA (0.48) LDHAEPHX2TLR4CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190262268-A1 ORAL MODIFIED RELEASE FORMULATIONS RUBICON RES PRIVATE LIMITED (IN) 2019-08-29 — — US claimed
WO-2018055641-A1 ORAL MODIFIED RELEASE FORMULATIONS RUBICON RESEARCH PRIVATE LIMITED (IN) 2018-03-29 — — WO claimed
EP-2254600-B1 NOVEL COMPOSITIONS AND USES THEREOF BIOSUSPENSIONS LTD (GB) 2017-05-17 — — EP claimed
US-20170128379-A1 MODIFIED RELEASE PHARMACEUTICAL PREPARATIONS RUBICON RESEARCH PRIVATE LIMITED (IN) 2017-05-11 — — US claimed
US-9254264-B2 Compositions and uses thereof BIOSUSPENSIONS LIMITED (GB) 2016-02-09 — — US claimed
WO-2016001937-A2 MODIFIED RELEASE PHARMACEUTICAL PREPARATIONS RUBICON RESEARCH PRIVATE LIMITED (IN) 2016-01-07 — — WO claimed
US-20110117019-A1 Novel Compositions and Uses Thereof BIOSUSPENSIONS LIMITED (GB) 2011-05-19 — — US claimed
EP-2254600-A1 NOVEL COMPOSITIONS AND USES THEREOF Biosuspensions Limited (GB) 2010-12-01 — — EP claimed
US-20100047360-A1 Use Of Polyamines In The Treatment Of Psoriasis Bioforskining Pharma AS (NO) 2010-02-25 — — US claimed
WO-2009098469-A1 NOVEL COMPOSITIONS AND USES THEREOF BIOSUSPENSIONS LIMITED (GB) 2009-08-13 — — WO claimed
WO-2009098475-A1 STRUCTURED SURFACTANT SYSTEMS AND USES THEREOF BIOSUSPENSIONS LIMITED (GB) 2009-08-13 — — WO claimed
CN-101489541-A Use of polyamines in the treatment of psoriasis BIOFORSKNING PHARMA AS (NO) 2009-07-22 — — CN claimed
EP-2004162-A1 USE OF POLYAMINES IN THE TREATMENT OF PSORIASIS Bioforskning Pharma AS (NO) 2008-12-24 — — EP claimed
US-20080124312-A1 Polyamine Compositions BIOFORSKNING AS (NO) 2008-05-29 — — US claimed
CN-101068601-A Polyamine compositions BIOFORSKNING AS (NO) 2007-11-07 — — CN claimed
WO-2007104981-A1 USE OF POLYAMINES IN THE TREATMENT OF PSORIASIS BIOFORSKNING PHARMA AS (NO) 2007-09-20 — — WO claimed
EP-1807042-A1 POLYAMINE COMPOSITIONS Bioforskning AS (NO) 2007-07-18 — — EP claimed
WO-2006048671-A1 POLYAMINE COMPOSITIONS BIOFORSKNING AS (NO) 2006-05-11 — — WO claimed
CN-116685305-A Cleaning composition 日本乐敦制药株式会社 2023-09-01 — — CN disclosed
EP-0775494-A1 PERORAL IMMUNOGEN COMPOSITION AND PROCESS FOR PRODUCING THE SAME THE NISSHIN OIL MILLS, LTD. (JP) 1997-05-28 — — EP disclosed